Jerome B Zeldis is Director of NEXGEL, INC.. Currently has a direct ownership of 106,664 shares of NXGL, which is worth approximately $521,586. The most recent transaction as insider was on Nov 20, 2024, when has been sold 3,636 shares (Common Stock) at a price of $2.75 per share, resulting in proceeds of $9,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 107K
3.53% 3M change
14.66% 12M change
Total Value Held $521,586

JEROME B ZELDIS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2024
BUY
Open market or private purchase
$9,999 $2.75 p/Share
3,636 Added 3.3%
106,664 Common Stock
Aug 23 2024
BUY
Open market or private purchase
$25,000 $2.5 p/Share
10,000 Added 8.85%
103,028 Common Stock
May 26 2023
BUY
Open market or private purchase
$11,700 $2.34 p/Share
5,000 Added 5.1%
93,028 Common Stock
Mar 25 2022
BUY
Open market or private purchase
$10,017 $1.89 p/Share
5,300 Added 5.68%
88,028 Common Stock
Dec 27 2021
BUY
Open market or private purchase
$49,910 $5.49 p/Share
9,091 Added 9.9%
82,728 Common Stock

Also insider at

PTCT
PTC THERAPEUTICS, INC. Healthcare
NEXI
NexImmune, Inc. Healthcare
SNGX
SOLIGENIX, INC. Healthcare
JBZ

Jerome B Zeldis

Director
South Plainfield, NJ

Track Institutional and Insider Activities on NXGL

Follow NEXGEL, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NXGL shares.

Notify only if

Insider Trading

Get notified when an Nexgel, Inc. insider buys or sells NXGL shares.

Notify only if

News

Receive news related to NEXGEL, INC.

Track Activities on NXGL